Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy

Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease that typically presents with greater severity in patients with underlying medical conditions or those who are immunosuppressed. We present a novel case series of three kidney transplant recipients with COVID-19 who recovered after receiving COVID-19 convalescent plasma (CCP) therapy. Physicians should be aware of this potentially useful treatment option. Larger clinical registries and randomized clinical trials should be conducted to further explore the clinical and allograft outcomes associated with CCP use in this population.

Automated summary

COVID-19 is a highly infectious viral disease that can be more severe in patients with underlying medical conditions. This study showed that kidney transplant recipients with COVID-19 could recover after receiving CCP therapy. Further research is needed to explore the clinical outcomes associated with CCP use in this population.